Association between atrial fibrillation and heart failure with different ejection fraction categories and its influence on outcomes

被引:11
作者
Xu, Hai-Xia [1 ]
Zhu, Yan-Min- [1 ]
Hua, Ying [1 ]
Huang, Yin-Hao [1 ]
Lu, Qi [1 ]
机构
[1] Nantong Univ, Dept Cardiol, Affiliated Hosp, 20 Xisi Rd, Chongchuan Dist 226001, Nantong, Peoples R China
关键词
Heart failure; ejection fraction; atrial fibrillation; outcomes; PROGNOSTIC-SIGNIFICANCE; SYSTOLIC FUNCTION; MIDRANGE; IMPACT; RISK; DYSFUNCTION; MORTALITY; THERAPY; DISEASE; TRIAL;
D O I
10.1080/00015385.2019.1610834
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:The important role of atrial fibrillation (AF) in different types of heart failure (HF) according to ejection fraction (EF) is much less explored. In this study, we compared AF in HF with preserved (HFpEF), mid-range (HFmrEF) and reduced (HFrEF) EF with regard to prevalence, association, and prognostic role. Methods and results:A total of 405 inpatients with HF between February 2014 and June 2016 were prospectively analysed in this study. Patients were divided into three groups: HFrEF group (n = 109, 26.9%), HFmrEF group (n = 94, 23.2%), and HFpEF group (n = 202, 49.8%). There was a higher prevalence of AF in patients in the HFpEF and HFmrEF groups than in patients in the HFrEF. Several baseline variables were found to be independently associated with AF, including age, coronary heart disease, heart rate, left atrial diameter, and left ventricular (LV) end-diastolic diameter, regardless of EF category after multivariable adjustment. In addition, AF was found to be a more powerful predictor of all-cause mortality, HF rehospitalisation, and the composite event of all-cause mortality or rehospitalisation in HFpEF and HFmrEF patients, but not in HFrEF patients. Conclusions:HFmrEF resembled HFpEF rather than HFrEF with regard to both a higher prevalence of AF and a greater risk of all-cause mortality, HF rehospitalisation, and the composite event of all-cause mortality or rehospitalisation.
引用
收藏
页码:423 / 432
页数:10
相关论文
共 34 条
[1]   Atrial Fibrillation and Heart Failure Treatment Considerations for a Dual Epidemic [J].
Anter, Elad ;
Jessup, Mariell ;
Callans, David J. .
CIRCULATION, 2009, 119 (18) :2516-2525
[2]  
CARSON PE, 1993, CIRCULATION, V87, P102
[3]   No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction [J].
Chamberlain, Alanna M. ;
Gersh, Bernard J. ;
Alonso, Alvaro ;
Kopecky, Stephen L. ;
Killian, Jill M. ;
Weston, Susan A. ;
Roger, Veronique L. .
HEART RHYTHM, 2017, 14 (06) :791-798
[4]   Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry [J].
Chioncel, Ovidiu ;
Lainscak, Mitja ;
Seferovic, Petar M. ;
Anker, Stefan D. ;
Crespo-Leiro, Maria G. ;
Harjola, Veli-Pekka ;
Parissis, John ;
Laroche, Cecile ;
Piepoli, Massimo Francesco ;
Fonseca, Candida ;
Mebazaa, Alexandre ;
Lund, Lars ;
Ambrosio, Giuseppe A. ;
Coats, Andrew J. ;
Ferrari, Roberto ;
Ruschitzka, Frank ;
Maggioni, Aldo P. ;
Filippatos, Gerasimos .
EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (12) :1574-1585
[5]   Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction [J].
Corell, Pernille ;
Gustafsson, Finn ;
Schou, Morten ;
Markenvard, John ;
Nielsen, Tonny ;
Hildebrandt, Per .
EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (03) :258-265
[6]   Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation - Observations from the Veterans Affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT) [J].
Deedwania, PC ;
Singh, BN ;
Ellenbogen, K ;
Fisher, S ;
Fletcher, R ;
Singh, SN .
CIRCULATION, 1998, 98 (23) :2574-2579
[7]   Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials [J].
Dries, DL ;
Exner, DV ;
Gersh, BJ ;
Domanski, MJ ;
Waclawiw, MA ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :695-703
[8]   Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction [J].
Dunlay, Shannon M. ;
Roger, Veronique L. ;
Weston, Susan A. ;
Jiang, Ruoxiang ;
Redfield, Margaret M. .
CIRCULATION-HEART FAILURE, 2012, 5 (06) :720-726
[9]   Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome [J].
Farmakis, Dimitrios ;
Simitsis, Panagiotis ;
Bistola, Vasiliki ;
Triposkiadis, Filippos ;
Ikonomidis, Ignatios ;
Katsanos, Spyridon ;
Bakosis, George ;
Hatziagelaki, Erifili ;
Lekakis, John ;
Mebazaa, Alexandre ;
Parissis, John .
CLINICAL RESEARCH IN CARDIOLOGY, 2017, 106 (05) :359-368
[10]   Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure - A report from the OPTIMIZE-HF registry [J].
Fonarow, Gregg C. ;
Stough, Wendy Gattis ;
Abraham, William T. ;
Albert, Nancy M. ;
Gheorghiade, Mihai ;
Greenberg, Barry H. ;
O'Connor, Christopher M. ;
Sun, Jie Lena ;
Yancy, Clyde W. ;
Young, James B. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (08) :768-777